4D Path
Belmont, US · Founded 2016 · Delaware corporation · 16 employees on LinkedIn
4D Path develops a cancer diagnostics technology that combines statistical physics with cancer biology to quantify cell cycle deregulations and tumor dynamics, generating indices that predict individual patient response to therapy. It works with cancer researchers and biopharma companies to guide personalized treatment selection and support drug discovery and development.
Founders & leadership
4D Path was founded in 2016 by Rodrigo Navarro-Banzer.
RN
Rodrigo Navarro-BanzerinCo-founder, President & CEO2016–2022Rodrigo Navarro-Banzer has launched and scaled startups in healthcare and data sectors, developing business models that combine industry knowledge with technology strategy.
RJ
Rodrigo Jose NavarroNamed on SEC filing
SM
Satabhisa MukhopadhyayNamed on SEC filing
MP
Mario PintoNamed on SEC filing
TD
Tathagata DasguptaNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$17.3M disclosed across 3 rounds · 2017–2023
▶$13MraisedMay 2023 · 49 investors · Other Health CareRule 506(b)
▶$13MraisedMay 2023 · 49 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Roberto LaganaDirector
- Rodrigo Jose NavarroExecutive Officer, Director
- Cristiano LeaoExecutive Officer
- Nicholas BeroExecutive Officer
- Mario PintoDirector
- Satabhisa MukhopadhyayExecutive Officer, Director
- Roberto EngelsDirector
- Tathagata DasguptaExecutive Officer, Director
- Offering amount
- $17M
- Amount sold
- $13M
- Proceeds to insiders
- $2.1M
- First sale
- Apr 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$4.1MraisedJul 2020 · 33 investors · Other Health CareRule 506(b)
▶$4.1MraisedJul 2020 · 33 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Satabhisa MukhopadhyayDirector
- Mario PintoDirector
- Rodrigo Jose NavarroExecutive Officer, Director
- Tathagata DasguptaDirector
- Offering amount
- $4.5M
- Amount sold
- $4.1M
- Proceeds to insiders
- $150K
- First sale
- Oct 2019
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$250KraisedSep 2017 · 1 investors · Other Health CareRule 506(b)
▶$250KraisedSep 2017 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Rodrigo Jose NavarroExecutive Officer, Director
- Satabhisa MukhopadhyayDirector
- Mario PintoDirector
- Tathagata DasguptaDirector
- Offering amount
- $700K
- Amount sold
- $250K
- Proceeds to insiders
- $100K
- First sale
- Jun 2017
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 4
by search overlapPathai5 shared keywordsAI-powered pathology for improved patient outcomes
4DMedical4 shared keywords4DMedical develops analytical software that extracts detailed lung function data from standard X-ray and CT scans, enabling non-invasive diagnosis and tailored treatment of respiratory conditions. Its technology serves clinicians and healthcare providers, including VA hospitals treating veterans exposed to toxic substances and airborne hazards.
Steam3 shared keywordsSteam is a digital platform for purchasing, downloading, and playing video games, serving both individual gamers and game developers worldwide.
Zillow3 shared keywordsZillow operates an online real estate marketplace where consumers can search homes for sale and rentals across US and Canadian cities, view mortgage rate information, and access home financing through Zillow Home Loans. It covers residential property listings, apartments and houses for rent, and mortgage services nationwide.
Companies competing with 4D Path for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does 4D Path do?
- 4D Path develops a cancer diagnostics technology that combines statistical physics with cancer biology to quantify cell cycle deregulations and tumor dynamics, generating indices that predict individual patient response to therapy. It works with cancer researchers and biopharma companies to guide personalized treatment selection and support drug discovery and development.
- Who founded 4D Path?
- 4D Path was founded by Rodrigo Navarro-Banzer in 2016.
- How much funding has 4D Path raised?
- 4D Path has disclosed $17.3M raised across 3 rounds.
- Where is 4D Path headquartered?
- 4D Path is headquartered in Belmont, US.